James Sanderson
Impact in
-
- Radiopharmaceutical Chemistry and Applications
- Monoclonal and Polyclonal Antibodies Research
- Medical Imaging Techniques and Applications
-
- Peptidase Inhibition and Analysis
Papers in
-
- Radiopharmaceutical Chemistry and Applications 8
- Monoclonal and Polyclonal Antibodies Research 6
-
- Biotin and Related Studies 3
- Co-authors
- Yukang LinJody SchultzDonald B. AxworthyT. Nageswara RaoPaul L. BeaumierAlan R. FritzbergS. KasinaJ. M. Reno
- Journals
- Bioconjugate Chemistry (2 papers)Rapid Communications in Mass Spectrometry (1 paper)Cancer Biotherapy and Radiopharmaceuticals (1 paper)Proceedings of the National Academy of Sciences (1 paper)Protein Science (1 paper)
- Partner nations
- United StatesUnited KingdomCanada
In The Last Decade
James Sanderson
10 papers receiving 505 citations
Peers
Comparison fields: 5 of 57
- Radiology, Nuclear Medicine and Imaging 389
- Oncology 136
- Pathology and Forensic Medicine 61
- Biotechnology 24
- Neurology 41
Countries citing papers authored by James Sanderson
This map shows the geographic impact of James Sanderson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James Sanderson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James Sanderson more than expected).
Fields of papers citing papers by James Sanderson
This network shows the impact of papers produced by James Sanderson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James Sanderson. The network helps show where James Sanderson may publish in the future.
Co-authorship network
The 25 scholars most cited alongside James Sanderson, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2004 | 9 | |
| 2 | Single-chain Fv-streptavidin substantially improved therapeutic index in multistep targeting directed at disialoganglioside GD2. | 2004 | 46 |
| 3 | Combination therapy with Pretarget CC49 radioimmunotherapy and gemcitabine prolongs tumor doubling time in a murine xenograft model of colon cancer more effectively than either monotherapy. | 2003 | 44 |
| 4 | 2001 | 28 | |
| 5 | 2001 | 63 | |
| 6 | A tetravalent single-chain antibody-streptavidin fusion protein for pretargeted lymphoma therapy. | 2000 | 108 |
| 7 | 1999 | 17 | |
| 8 | 1998 | 16 | |
| 9 | Development and biologic evaluation of a kit for preformed chelate technetium-99m radiolabeling of an antibody Fab fragment using a diamide dimercaptide chelating agent. | 1991 | 64 |
| 10 | 1988 | 133 |
About James Sanderson
James Sanderson is a scholar working on Radiology, Nuclear Medicine and Imaging, Cell Biology, Oncology, Biotechnology and Neurology, having authored 10 papers that have together received 528 indexed citations. Recurring topics across this work include Radiopharmaceutical Chemistry and Applications (8 papers), Monoclonal and Polyclonal Antibodies Research (6 papers), HER2/EGFR in Cancer Research (3 papers), Biotin and Related Studies (3 papers), Medical Imaging and Pathology Studies (2 papers), Pancreatic and Hepatic Oncology Research (1 paper), Neuroblastoma Research and Treatments (1 paper) and Cancer Research and Treatments (1 paper). The work is most often cited by research in Radiology, Nuclear Medicine and Imaging (389 citations), Oncology (136 citations), Pathology and Forensic Medicine (61 citations), Biotechnology (24 citations) and Neurology (41 citations). James Sanderson has collaborated with scholars based in United States, United Kingdom and Canada. Frequent co-authors include Yukang Lin, Jody Schultz, Donald B. Axworthy, T. Nageswara Rao, Paul L. Beaumier, Alan R. Fritzberg, S. Kasina, J. M. Reno, Sibylle Wilbert and D. Scott Wilbur. Their work appears in journals such as Bioconjugate Chemistry, Rapid Communications in Mass Spectrometry, Cancer Biotherapy and Radiopharmaceuticals, Proceedings of the National Academy of Sciences and Protein Science.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.